Related Experiment Video
Updated: Aug 14, 2026

Identification of Intracellular Signaling Events Induced in Viable Cells by Interaction with Neighboring Cells Undergoing Apoptotic Cell Death
Published on: December 27, 2016
Failure of glucagon to induce hepatic phosphoenolpyruvate carboxykinase in endotoxic shock
1Department of Physiology, University of Oklahoma Health Sciences Center, Oklahoma City 73190.
Abstract:
We have determined that one reason for diminished PEPCK activity during endotoxemia is the inhibition of glucocorticoid action in hepatic cells. Since glucocorticoid and glucagon hormones act cooperatively to regulate the expression of PEPCK mRNA, we examined whether endotoxin also inhibits the action of glucagon to induce this enzyme. Treated mice were injected intraperitoneally with endotoxin and glucose after a 24 hr fast and given ad libitum access to food and water. Control mice received the same amount of glucose and access to food and water. All mice were given intravenous injections of glucagon for 3 consecutive hours before euthanasia. Blood was analyzed for glucose concentrations, and the liver was assayed for PEPCK activity. Refeeding control mice after a 24 hr fast increased plasma glucose levels to 173 +/- 14 mg/dL and decreased PEPCK activity to 20.6 +/- 2.0 units/mg liver. Subsequent administration of exogenous glucagon further increased plasma glucose to 224 +/- 17 mg/dL and hepatic PEPCK to 31.4 +/- 1.4 units/mg liver. Refeeding endotoxin-treated mice after a 24 hr fast slightly increased plasma glucose levels to 75 +/- 4 mg/dL but had no effect on PEPCK activity. Subsequent glucagon administration had no effect on plasma glucose levels (75 +/- 1.0 mg/dL) or hepatic PEPCK activities (18.8 +/- 5.0 units/mg liver). Therefore, glucagon action to increase liver PEPCK activity and plasma glucose levels was inhibited in endotoxin-treated mice.
Insights
Endotoxemia inhibits glucagon
Area of Science:
- Biochemistry
- Endocrinology
- Molecular Biology
Background:
- Glucocorticoids and glucagon cooperatively regulate phosphoenolpyruvate carboxykinase (PEPCK) mRNA expression.
- Endotoxemia is known to diminish PEPCK activity, partly due to inhibited glucocorticoid action.
- The effect of endotoxin on glucagon's induction of PEPCK remains unclear.
Purpose of the Study:
- To investigate whether endotoxin inhibits glucagon's action to induce hepatic PEPCK activity.
Main Methods:
- Mice were fasted and treated with endotoxin or saline.
- Animals received glucose and ad libitum access to food and water.
- Intravenous glucagon was administered, followed by analysis of plasma glucose and liver PEPCK activity.
Main Results:
- In control mice, glucagon increased plasma glucose and hepatic PEPCK activity.
- In endotoxin-treated mice, glucagon failed to increase plasma glucose or PEPCK activity.
- Endotoxin significantly inhibited glucagon's ability to raise plasma glucose and PEPCK levels.
Conclusions:
- Glucagon's action to stimulate PEPCK activity and plasma glucose is inhibited during endotoxemia.
- This finding highlights a mechanism by which endotoxemia disrupts glucose homeostasis.
Related Concept Videos
Cell Specific Gene Expression
cAMP-dependent Protein Kinase Pathways
Inborn Errors of Metabolism
Glucose Homeostasis: Pancreatic Islets and Insulin Secretion
Insulin and C-peptide are co-secreted in...
Hypoglycemia and Glucagon
Acute Pancreatitis II: Pathophysiology

